Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Genetic Syndromes & Gene Therapy|April 9, 2013
High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral VectorsBabak Moghimi, Irene Zolotukhin, Brandon K Sack, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2014
Immune tolerance induction to factor IX through B cell gene transfer: TLR9 signaling delineates between tolerogenic and immunogenic B cellsXiaomei Wang, Babak Moghimi, Irene Zolotukhin, et al.
Journal of Translational Medicine|January 28, 2014
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BGeoffrey L Rogers, Ashley T Martino, Irene Zolotukhin, et al.
Molecular Therapy. Methods & Clinical Development|October 15, 2016
Potential for cellular stress response to hepatic factor VIII expression from AAV vectorIrene Zolotukhin, David M Markusic, Brett Palaschak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
A new method for recombinant adeno-associated virus vector delivery to murine diaphragmCathryn Mah, Thomas J Fraites, Kerry O Cresawn, et al.
Virus Research|October 3, 2019
Biodistribution of adeno-associated virus type 2 with mutations in the capsid that contribute to heparan sulfate proteoglycan bindingOleg S Gorbatyuk, Kenneth H Warrington, Marina S Gorbatyuk, et al.
Human Gene Therapy|March 5, 2003
Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A miceCathryn Mah, Rita Sarkar, Irene Zolotukhin, et al.
Development (Cambridge, England)|June 1, 2004
Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe diseaseMary Rucker, Thomas J Fraites, Stacy L Porvasnik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2002
Improved method of recombinant AAV2 delivery for systemic targeted gene therapyCathryn Mah, Thomas J Fraites, Irene Zolotukhin, et al.
Frontiers in Immunology|June 17, 2021
Effect of CpG Depletion of Vector Genome on CD8<sup>+</sup> T Cell Responses in AAV Gene TherapyThais B Bertolini, Jamie L Shirley, Irene Zolotukhin, et al.
Pageof 3